WO2007048843A3 - Imidazo-pyridin-haltige beta-agonisten, verfahren zu deren herstellung und deren verwendung als arzneimittel - Google Patents

Imidazo-pyridin-haltige beta-agonisten, verfahren zu deren herstellung und deren verwendung als arzneimittel Download PDF

Info

Publication number
WO2007048843A3
WO2007048843A3 PCT/EP2006/067875 EP2006067875W WO2007048843A3 WO 2007048843 A3 WO2007048843 A3 WO 2007048843A3 EP 2006067875 W EP2006067875 W EP 2006067875W WO 2007048843 A3 WO2007048843 A3 WO 2007048843A3
Authority
WO
WIPO (PCT)
Prior art keywords
drugs
producing
imidazo
beta agonists
containing beta
Prior art date
Application number
PCT/EP2006/067875
Other languages
English (en)
French (fr)
Other versions
WO2007048843A2 (de
Inventor
Thomas Trieselmann
Rainer Walter
Matthew R Netherton
Bradford S Hamilton
Original Assignee
Boehringer Ingelheim Int
Boehringer Ingelheim Pharma
Thomas Trieselmann
Rainer Walter
Matthew R Netherton
Bradford S Hamilton
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int, Boehringer Ingelheim Pharma, Thomas Trieselmann, Rainer Walter, Matthew R Netherton, Bradford S Hamilton filed Critical Boehringer Ingelheim Int
Priority to CA002627403A priority Critical patent/CA2627403A1/en
Priority to JP2008537113A priority patent/JP2009513607A/ja
Priority to US12/091,828 priority patent/US20080269281A1/en
Priority to EP06819170A priority patent/EP1945304A2/de
Publication of WO2007048843A2 publication Critical patent/WO2007048843A2/de
Publication of WO2007048843A3 publication Critical patent/WO2007048843A3/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Die vorliegende Erfindung betrifft neue Beta-Agonisten der allgemeinen Formel (I), wobei die Reste R1 bis R4 die in den Ansprüchen und der Beschreibung genannten Bedeutungen haben, deren Tautomere, deren Racemate, deren Enantiomere, deren Diastereomere, deren Gemische, deren Solvate, deren Hydrate, deren Prodrugs und deren Salze, insbesondere deren physiologisch verträgliche Salze mit anorganischen oder organischen Säuren oder Basen, Verfahren zur Herstellung dieser Verbindungen sowie deren Verwendung als Arzneimittel.
PCT/EP2006/067875 2005-10-28 2006-10-27 Imidazo-pyridin-haltige beta-agonisten, verfahren zu deren herstellung und deren verwendung als arzneimittel WO2007048843A2 (de)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CA002627403A CA2627403A1 (en) 2005-10-28 2006-10-27 Imidazo-pyridine containing beta agonists, method for producing them and their use as drugs
JP2008537113A JP2009513607A (ja) 2005-10-28 2006-10-27 新規ベータ−アゴニスト、それらの製造方法及び薬物としてのそれらの使用
US12/091,828 US20080269281A1 (en) 2005-10-28 2006-10-27 Novel Beta-Agonists, Method for Producing Them and Their Use as Drugs
EP06819170A EP1945304A2 (de) 2005-10-28 2006-10-27 Imidazo-pyridin-haltige beta-agonisten, verfahren zu deren herstellung und deren verwendung als arzneimittel

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005052103A DE102005052103A1 (de) 2005-10-28 2005-10-28 Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
DE102005052103.7 2005-10-28

Publications (2)

Publication Number Publication Date
WO2007048843A2 WO2007048843A2 (de) 2007-05-03
WO2007048843A3 true WO2007048843A3 (de) 2007-08-16

Family

ID=37834107

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2006/067875 WO2007048843A2 (de) 2005-10-28 2006-10-27 Imidazo-pyridin-haltige beta-agonisten, verfahren zu deren herstellung und deren verwendung als arzneimittel

Country Status (6)

Country Link
US (1) US20080269281A1 (de)
EP (1) EP1945304A2 (de)
JP (1) JP2009513607A (de)
CA (1) CA2627403A1 (de)
DE (1) DE102005052103A1 (de)
WO (1) WO2007048843A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004021779A1 (de) * 2004-04-30 2005-11-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
DE102005052127A1 (de) * 2005-10-28 2007-05-03 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue indol-haltige Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
DE102005052101A1 (de) * 2005-10-28 2007-05-03 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004039784A1 (de) * 2002-10-31 2004-05-13 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue phenylethanolaminderivate und deren verwendung als beta-3-agonisten
EP1447400A1 (de) * 2001-10-25 2004-08-18 Asahi Kasei Pharma Corporation Bicyclische verbindung

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1447400A1 (de) * 2001-10-25 2004-08-18 Asahi Kasei Pharma Corporation Bicyclische verbindung
WO2004039784A1 (de) * 2002-10-31 2004-05-13 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue phenylethanolaminderivate und deren verwendung als beta-3-agonisten

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
HIROSHI HARADA ET AL: "Discovery of a Novel and Potent Human and Rat b3-Adrenergic Receptor Agonist, [3-[(2R)-[[(2R)-(3-Chlorophenyl)-2-hydroxyethyl]amino]propyl]-1H-indol-7-yloxy]acetic Acid", CHEMICAL & PHARMACEUTICAL BULLETIN, vol. 53, no. 2, February 2005 (2005-02-01), pages 184-198, XP002424904 *

Also Published As

Publication number Publication date
EP1945304A2 (de) 2008-07-23
CA2627403A1 (en) 2007-05-03
DE102005052103A1 (de) 2007-05-03
JP2009513607A (ja) 2009-04-02
WO2007048843A2 (de) 2007-05-03
US20080269281A1 (en) 2008-10-30

Similar Documents

Publication Publication Date Title
WO2009065919A3 (de) Organische verbindungen
WO2009065920A3 (de) Verbindungen
WO2005103037A3 (de) Ausgewählte cgrp-antagonisten, verfahren zu deren herstellung sowie deren verwendung als arzneimittel
TW200738693A (en) Substituted biaryls, process for their manufacture and use thereof as medicaments
TW200602338A (en) Selected CGRP antagonists, process for preparing them and their use as pharmaceutical compositions
TW200738692A (en) New substituted glycinamides, process for their manufacture and use thereof as medicaments
WO2004037811A8 (de) Ausgewählte cgrp-antagonisten, verfahren zu deren herstellung sowie deren verwendung als arzneimittel
GB0719180D0 (en) New process
WO2007015017A3 (fr) Nouveaux derives de polyquinoleines et leur utilisation therapeutique
WO2008079787A3 (en) Glucokinase activators
WO2007028135A3 (en) Imidazopyridine compounds
TW200603799A (en) Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions
WO2008116107A3 (en) Piperazine derivatives as glucokinase activators
WO2007061923A3 (en) Glucokinase activators
WO2008005368A3 (en) Piperazines as p2x7 antagonists
NO20075734L (no) Tiofenforbindelser og trombopoietin reseptoractivatorer
MY146623A (en) Substituted prolinamides, manufacturing, and the use thereof as medicaments
PL1904482T3 (pl) Pochodne indolilomaleimidowe
PT1753712E (pt) Derivados de amino-propanol
WO2007048841A3 (de) Neue indol-haltige beta-agonisten, verfahren zu deren herstellung und deren verwendung als arzneimittel
WO2007020261A3 (de) Ausgewählte cgrp-antagonisten, verfahren zu deren herstellung sowie deren verwendung als arzneimittel
MX2010003849A (es) Antagonistas de cgrp.
WO2008080891A3 (en) Process for the synthesis of derivatives of 3-amino-tetrahydrofuran-3-carboxylic acid and use thereof as medicaments
HK1114516A1 (en) Substituted sulfoxide compounds, methods for preparing the same and use thereof
WO2009034029A3 (de) 1-substituierte 4 -heterocyclylpiperidine als cgrp antagonisten

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2006819170

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2627403

Country of ref document: CA

ENP Entry into the national phase

Ref document number: 2008537113

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 12091828

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 2006819170

Country of ref document: EP